Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Predictive Oncology Confirms Indications of Interest for Skyline Medical Business
MINNEAPOLIS , Dec. 05, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.  (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has received indications of interest from
View HTML
Toggle Summary Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
MINNEAPOLIS , Nov. 25, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that based on a notification letter (the “Notification
View HTML
Toggle Summary Predictive Oncology Secures $15,000,000 Equity Line
MINNEAPOLIS , Nov. 20, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc.  (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it entered into a $15 million common stock purchase
View HTML
Toggle Summary Predictive Oncology CEO Discusses Corporate Milestones, Unique Approach to Cancer Research in Exclusive Broadcast
NEW YORK , Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery, today announces the broadcast of its
View HTML
Toggle Summary Predictive Oncology Inc. Reports Q3 Results; Revenues Increase 58%
MINNEAPOLIS , Nov. 15, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. , (NASDAQ: POAI) (“Predictive Oncology” or “the Company”) an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through
View HTML
Toggle Summary Predictive Oncology Featured in Broadcast Evaluating Targeted Cancer Therapies, Higher Survival Rates
NEW YORK , Nov. 07, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio –  Predictive Oncology (NASDAQ: POAI) announces the availability of a broadcast titled, “New Hope in the Battle Against Ovarian Cancer.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/L4Kxb To read the full
View HTML
Toggle Summary Predictive Oncology Featured in Publication Discussing the Impact of Artificial Intelligence on Cancer Treatment
NEW YORK , Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology (NASDAQ: POAI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.
View HTML
Toggle Summary Predictive Oncology Reaches First Milestone in Building AI-driven Predictive Models of Ovarian Cancer
Helomics subsidiary begins sequencing retrospective ovarian cancer cases from UPMC-Magee collaboration, advancing POAI’s CancerQuest 2020 initiative MINNEAPOLIS , Oct. 31, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying
View HTML
Toggle Summary Predictive Oncology (NASDAQ: POAI) Featured in Broadcast on Big Data, AI’s Potential to Fight Cancer
NEW YORK , Oct. 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio –   Predictive Oncology (NASDAQ: POAI) announces the availability of a broadcast titled, “Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics.” To hear the
View HTML
Toggle Summary Predictive Oncology (NASDAQ: POAI) Featured in NetworkNewsWire Publication Discussing Power of Data Plus AI in Precision Medicine
NEW YORK , Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire —  Predictive Oncology (NASDAQ: POAI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.
View HTML